The illustration shows a fluorescence image of viral-DNA-Rad50-CARD9 complexes (yellow) in the cytoplasm (transmission light) of a cell. After infecting the cell with a DNA virus, the scientists mark the individual molecules to be observed in the cell with different fluorescent dyes. Here, the DNA is represented in blue/magenta, Rad50 in green and Card9 in red. Credit: A. Rottach / LMU
Cells have to protect themselves: against damage in their genetic material for one thing, but also against attack from the outside, by viruses for example. They do this by using different mechanisms: special proteins search out and detect defects in the cell's own DNA, while the immune system takes action against intruders. Scientists from Technische Universität München and Ludwig-Maximilians-Universität München have now shown that the two protective mechanisms are linked by a shared protein.
In human cells, DNA occurs only in the cell nucleus as the carrier of genetic information. In order to protect it, specialized proteins regularly scan the individual strands for defects, and repair them. One example of this is the protein Rad50, a DNA sensor that binds to DNA and detects defective sites. A team of scientists headed by Prof. Jürgen Ruland of the TUM together with colleagues from the LMU have now discovered another important task performed by Rad50.
There is normally no DNA in the cytoplasm surrounding the cell nucleus. However, if any does turn up there, it is frequently foreign DNA from a virus, for instance, that has infected the cell. Just like humans, some types of viruses use DNA to carry their genetic information. Thus the innate immune system has developed alarm mechanisms to detect foreign DNA in cytoplasm quickly and effectively, and activate the immune system by producing messenger substances.
However, it remains largely unclear just how this activation process occurs in the cytoplasm. In their study, lead author Dr. Susanne Roth and her colleagues have now shown that the DNA sensor Rad50 from the cell nucleus is also an important trigger for antiviral defense. "It is very surprising even for us that Rad50, which specializes in DNA in the cell nucleus, also detects foreign viral DNA and acts as a connecting link for the corresponding immune response", says Prof. Jürgen Ruland, explaining the significance of the findings.
One protein - two functions
In their experiments, the participating scientists infected immune cells with a virus that introduced its DNA into the cytoplasm. They were able to show that Rad50 bound to the viral DNA in the cytoplasm, even though it normally docks onto damaged DNA in the cell nucleus. A crucial factor was that Rad50 interacted with a specific signal protein (CARD9) of the immune system at the same time, forming a complex. The researchers succeeded in demonstrating this connection in cells for the first time.
The formation of the complex activated a signal transduction pathway in the cell which ended with production of the messenger substance interleukin 1β. This vital "global player" of the immune system is responsible for the onset of fever as a defense mechanism against pathogens, but also has a role in autoimmune diseases, such as rheumatoid arthritis.
In order to confirm their results, the researchers then used cells containing either no Rad50 or no CARD9, and again introduced DNA into their cytoplasm. Both cell types then produced far less interleukin 1β, as the Rad50-CARD9 complex could not be formed in order to activate the alarm system.
"Too much or too little of IL-1β can lead to a defective immune response or chronic disease, so its production must be strictly regulated by the body", explains Jürgen Ruland. "Now that we know Rad50 and CARD9 are important triggers for the alarm system and IL-1β production, we can gain a better understanding of many immune responses and develop strategies to influence them therapeutically."
Explore further: Degradation of viral DNA in the cell nucleus opens new Hepatitis B treatment possibilities
More information: Susanne Roth, Andrea Rottach, Amelie S Lotz-Havla, Verena Laux, Andreas Muschaweckh, Søren W Gersting, Ania C Muntau, Karl-Peter Hopfner, Lei Jin, Katelynd Vanness, John H J Petrini, Ingo Drexler, Heinrich Leonhardt and Jürgen Ruland, Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1β production, Nature Immunology, 2014. DOI: 10.1038/ni.2888
Medical Xpress on facebook
Related Stories
Degradation of viral DNA in the cell nucleus opens new Hepatitis B treatment possibilities
Feb 21, 2014
Scientists from the Helmholtz Zentrum München and the Technische Universität München have discovered how the viral DNA of the hepatitis B virus (HBV) can be degraded in the cell nucleus of liver cells, consequently allowing ...
A braking system for immune responses: Researchers find receptor for uric acid crystals
Mar 20, 2014
For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control ...
Researchers identify new enzyme that acts as innate immunity sensor
Feb 15, 2013
Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections.
Tracking viral DNA in the cell
Oct 16, 2013
Cell biologists and chemists from the University of Zurich reveal how viral DNA traffics in human cells. They have developed a new method to generate virus particles containing labeled viral DNA genomes. This allowed them ...
How a shape-shifting DNA-repair machine fights cancer
Feb 03, 2014
(Phys.org) —Maybe you've seen the movies or played with toy Transformers, those shape-shifting machines that morph in response to whatever challenge they face. It turns out that DNA-repair machines in your ...
Recommended for you
Modulating your own immune response
May 06, 2014
With the help of simple techniques like breathing exercises, meditation and repeated exposure to cold, you can activate the autonomic nervous system and inhibit the response of your immune system. Researchers ...
Immune cells outsmart bacterial infection by dying, study shows
May 05, 2014
A new study led by scientists at the University of Pennsylvania School of Veterinary Medicine has painted a clearer picture of the delicate arms race between the human immune system and a pathogen that seeks to infect and ...
Outwitting immunity to treat disease: Start-up raises 33 millions CHF
May 05, 2014
EPFL start-up Anokion has the immune system in its sights. The company has developed technology for retraining white blood cells that holds promise for treating autoimmune, allergic, and a number of other ...
Genome study identifies three possible drug candidates for autoimmune diseases
May 02, 2014
(Medical Xpress)—New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, ...
Asthma sufferers may be prone to bone loss
May 01, 2014
Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of All ...
Five things to know about seasonal allergies
May 01, 2014
Seasonal allergies are one of the most common medical problems in America, with around 20 percent of people affected. That means that if you do not personally have allergies, chances are a close relative ...
User comments
© Medical Xpress 2011-2014, Science X network
The illustration shows a fluorescence image of viral-DNA-Rad50-CARD9 complexes (yellow) in the cytoplasm (transmission light) of a cell. After infecting the cell with a DNA virus, the scientists mark the individual molecules to be observed in the cell with different fluorescent dyes. Here, the DNA is represented in blue/magenta, Rad50 in green and Card9 in red. Credit: A. Rottach / LMU
Cells have to protect themselves: against damage in their genetic material for one thing, but also against attack from the outside, by viruses for example. They do this by using different mechanisms: special proteins search out and detect defects in the cell's own DNA, while the immune system takes action against intruders. Scientists from Technische Universität München and Ludwig-Maximilians-Universität München have now shown that the two protective mechanisms are linked by a shared protein.
In human cells, DNA occurs only in the cell nucleus as the carrier of genetic information. In order to protect it, specialized proteins regularly scan the individual strands for defects, and repair them. One example of this is the protein Rad50, a DNA sensor that binds to DNA and detects defective sites. A team of scientists headed by Prof. Jürgen Ruland of the TUM together with colleagues from the LMU have now discovered another important task performed by Rad50.
There is normally no DNA in the cytoplasm surrounding the cell nucleus. However, if any does turn up there, it is frequently foreign DNA from a virus, for instance, that has infected the cell. Just like humans, some types of viruses use DNA to carry their genetic information. Thus the innate immune system has developed alarm mechanisms to detect foreign DNA in cytoplasm quickly and effectively, and activate the immune system by producing messenger substances.
However, it remains largely unclear just how this activation process occurs in the cytoplasm. In their study, lead author Dr. Susanne Roth and her colleagues have now shown that the DNA sensor Rad50 from the cell nucleus is also an important trigger for antiviral defense. "It is very surprising even for us that Rad50, which specializes in DNA in the cell nucleus, also detects foreign viral DNA and acts as a connecting link for the corresponding immune response", says Prof. Jürgen Ruland, explaining the significance of the findings.
One protein - two functions
In their experiments, the participating scientists infected immune cells with a virus that introduced its DNA into the cytoplasm. They were able to show that Rad50 bound to the viral DNA in the cytoplasm, even though it normally docks onto damaged DNA in the cell nucleus. A crucial factor was that Rad50 interacted with a specific signal protein (CARD9) of the immune system at the same time, forming a complex. The researchers succeeded in demonstrating this connection in cells for the first time.
The formation of the complex activated a signal transduction pathway in the cell which ended with production of the messenger substance interleukin 1β. This vital "global player" of the immune system is responsible for the onset of fever as a defense mechanism against pathogens, but also has a role in autoimmune diseases, such as rheumatoid arthritis.
In order to confirm their results, the researchers then used cells containing either no Rad50 or no CARD9, and again introduced DNA into their cytoplasm. Both cell types then produced far less interleukin 1β, as the Rad50-CARD9 complex could not be formed in order to activate the alarm system.
"Too much or too little of IL-1β can lead to a defective immune response or chronic disease, so its production must be strictly regulated by the body", explains Jürgen Ruland. "Now that we know Rad50 and CARD9 are important triggers for the alarm system and IL-1β production, we can gain a better understanding of many immune responses and develop strategies to influence them therapeutically."
Explore further: Degradation of viral DNA in the cell nucleus opens new Hepatitis B treatment possibilities
More information: Susanne Roth, Andrea Rottach, Amelie S Lotz-Havla, Verena Laux, Andreas Muschaweckh, Søren W Gersting, Ania C Muntau, Karl-Peter Hopfner, Lei Jin, Katelynd Vanness, John H J Petrini, Ingo Drexler, Heinrich Leonhardt and Jürgen Ruland, Rad50-CARD9 interactions link cytosolic DNA sensing to IL-1β production, Nature Immunology, 2014. DOI: 10.1038/ni.2888
Medical Xpress on facebook
Related Stories
Degradation of viral DNA in the cell nucleus opens new Hepatitis B treatment possibilities
Feb 21, 2014
Scientists from the Helmholtz Zentrum München and the Technische Universität München have discovered how the viral DNA of the hepatitis B virus (HBV) can be degraded in the cell nucleus of liver cells, consequently allowing ...
A braking system for immune responses: Researchers find receptor for uric acid crystals
Mar 20, 2014
For the first time, researchers have identified a receptor on human cells that specifically recognizes crystals. It is found on immune cells and binds uric acid crystals, which trigger gout but also control ...
Researchers identify new enzyme that acts as innate immunity sensor
Feb 15, 2013
Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections.
Tracking viral DNA in the cell
Oct 16, 2013
Cell biologists and chemists from the University of Zurich reveal how viral DNA traffics in human cells. They have developed a new method to generate virus particles containing labeled viral DNA genomes. This allowed them ...
How a shape-shifting DNA-repair machine fights cancer
Feb 03, 2014
(Phys.org) —Maybe you've seen the movies or played with toy Transformers, those shape-shifting machines that morph in response to whatever challenge they face. It turns out that DNA-repair machines in your ...
Recommended for you
Modulating your own immune response
May 06, 2014
With the help of simple techniques like breathing exercises, meditation and repeated exposure to cold, you can activate the autonomic nervous system and inhibit the response of your immune system. Researchers ...
Immune cells outsmart bacterial infection by dying, study shows
May 05, 2014
A new study led by scientists at the University of Pennsylvania School of Veterinary Medicine has painted a clearer picture of the delicate arms race between the human immune system and a pathogen that seeks to infect and ...
Outwitting immunity to treat disease: Start-up raises 33 millions CHF
May 05, 2014
EPFL start-up Anokion has the immune system in its sights. The company has developed technology for retraining white blood cells that holds promise for treating autoimmune, allergic, and a number of other ...
Genome study identifies three possible drug candidates for autoimmune diseases
May 02, 2014
(Medical Xpress)—New pharmaceuticals to fight autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis and psoriasis, may be identified more effectively by adding genome analysis to standard drug screening, ...
Asthma sufferers may be prone to bone loss
May 01, 2014
Some of the 26 million Americans with asthma may also be prone to bone loss. According to a study published today in the May issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of All ...
Five things to know about seasonal allergies
May 01, 2014
Seasonal allergies are one of the most common medical problems in America, with around 20 percent of people affected. That means that if you do not personally have allergies, chances are a close relative ...
User comments
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment